One Call Boston Consulting Group Matrix
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
One Call Bundle
See the Bigger Picture
This snapshot shows where products land—Stars, Cash Cows, Dogs, or Question Marks—but the full One Call BCG Matrix gives you the playbook. Buy the complete report for quadrant-by-quadrant placement, data-driven recommendations, and ready-to-present Word and Excel files. Skip the guesswork and act with confidence.
Stars
Home Health & Field Care Coordination
High-demand, high-growth segment as payers push recovery at home; the U.S. home health market is expanding and Medicare Advantage enrollment surpassed 30 million in 2024, driving volume. One Call’s broad network delivers strong share and rapid placements, keeping cash cycling because cases are complex and frequent. Invest to scale coverage, nurse oversight, and turnaround time to lock in leadership and margin capture.
Transportation & Language Platform
Claims are increasingly complex and multilingual—One Call reports handling over 1.2M multilingual interactions in 2024, crucial for timely recoveries and 15% faster claims resolution for non-English speakers.
Digital scheduling and real-time tracking cut no-shows by ~28% in 2024, boosting outcomes and payer retention; one major payer reported 12% lower readmission spend when using One Call tech.
Market share remains strong with ~22% penetration in specialty transportation; the US non-emergent medical transportation market grew 8.7% in 2024 as workforces disperse.
Continued investment in technology and CX (R&D spend up 18% YoY in 2024) is essential to deepen network effects and lock in payer partnerships.
Catastrophic/Complex Care & Home Modifications
High acuity, high cost cases drive strategy: the top 5% of members account for ~50% of medical spend (2024), making catastrophic care a high-value growth lane. Deep vendor benches and case know-how win referrals and raise defensibility. Revenue per case often ranges $50k–$200k with high cash usage. Prioritize clinical playbooks and faster time-to-service to lock referrals and outcomes.
Diagnostics Coordination (Advanced Imaging)
MRI/CT utilization in workers’ compensation remained steady-to-rising in 2024 as MSK and trauma claims drove demand; MSK accounted for about 60% of WC claims in 2024. One Call’s fast access and scheduling convert into high market share across multiple geographies, though cash burn toward provider payments and service SLAs is material; the operational flywheel remains intact. Continue investing in turnaround time, prior-authorization support, and outcomes data to preserve share and margin.
- 2024 MSK share ~60%
- Prior-auth and turnaround investments improve utilization control
- Provider payments and SLAs drive near-term cash burn
- Outcomes data key to long-term value capture
Outcomes-Driven Provider Routing
Outcomes-Driven Provider Routing steers injured workers to top-performing clinics, cutting claim duration and total medical spend; 2024 industry analyses show median claim duration reductions around 25% and medical cost savings near 15%, outcomes payers demand. Early 2024 payer pilots and partner rollouts indicate accelerating adoption and scalable growth. A growing data moat from volume enables benchmarking and payer reporting to lock in default status.
- Tag: duration↓ ~25% (2024)
- Tag: cost↓ ~15% (2024)
- Tag: adoption: early payer pilots, accelerating
- Tag: moat: analytics + benchmarking + reporting
MA >30M, specialty transport ~22% share; tech trims no-shows ~28%, readmission spend 12%
High-growth Stars: U.S. home health and NEMT demand rose in 2024 (MA enrollment >30M), driving One Call’s ~22% specialty transport share and 8.7% market growth. Tech cuts no-shows ~28% and readmission spend 12%. MSK/WC cases ~60% share; top 5% members ≈50% spend, revenue per high-acuity case $50k–$200k. R&D +18% YoY secures scale and outcomes moat.
| Metric | 2024 |
|---|---|
| Medicare Advantage | >30M enrollees |
| Transport share | ~22% |
| Market growth | 8.7% |
| R&D spend YoY | +18% |
What is included in the product
Detailed Word Document
One Call BCG Matrix: concise quadrant-by-quadrant review with strategic actions—invest, hold, divest.
Customizable Excel Spreadsheet
One-page BCG snapshot placing each business unit in a quadrant to end analysis guesswork and speed C-level decisions
Cash Cows
Physical Therapy Network Management
Physical Therapy Network Management is a mature, high-volume, repeatable cash cow within One Call, servicing a US outpatient PT market ~38B in 2024 with stable utilization. Margin benefits from scale, standardized rates and consistent referrals drive EBITDA margins typically in the high teens to mid-20s. Low promo spend (often <5% of revenue) because relationships and SLAs do the heavy lifting. Milk efficiently while investing in ops automation to lift margin and throughput.
DME, Prosthetics & Orthotics Fulfillment
DME, prosthetics & orthotics fulfillment is an essential, high-margin cash cow for One Call with negotiated pricing and predictable yields; industry estimates put the global DME market near 170B USD in 2024 with mid-single-digit growth. Inventory and logistics processes are optimized, delivering steady cash flow to fund newer bets. Further tightening sourcing and last-mile coordination can widen spreads and bolster ROI.
Dental & Hearing Services for WC
Dental and hearing services in WC are niche but steady—OSHA estimates about 22 million US workers face hazardous noise exposure, keeping hearing care necessary after injuries. One Call’s deep provider panel shortens adjuster search time and reduces administrative friction. With low market growth but stable margins and WC medical spend north of $40B annually, prioritize maintaining quality and access and avoid heavy expansion spend.
Standard Imaging Scheduling (X-ray/Ultrasound)
Standard imaging scheduling (X-ray/Ultrasound) is a commodity volume driver with strong share anchored by existing payer contracts; by 2024 outpatient diagnostic imaging volumes returned near 2019 levels, delivering steady cash despite thin growth. High throughput and no-drama execution create positive free cash flow; keep SLAs tight, automate authorizations, and ride the base.
- High-margin cash flow from repeat, low-variation services
- SLA target <48 hours to preserve fill rates
- Authorization automation lowers manual touches and denials
- Major payers represent the majority of booked volume
Pharmacy Ancillary Coordination
Pharmacy Ancillary Coordination is not a headline service but delivers sticky, recurring revenue by embedding with core lines; it supports compliance and fast workflows while leveraging a mature market where Medicare Part D covered roughly 49 million enrollees in 2024 and U.S. prescription spending remained >$575B (2023), yielding stable rebate and fee structures and steady contribution margins.
- Sticky recurring revenue
- Cross-sell touchpoints
- Mature market, stable rebates/fees
- Compliance and workflow speed
Ancillary cash cows: PT, DME/P&O, imaging, pharmacy fuel repeatable high-margin cash flow
One Call cash cows—PT network, DME/P&O, dental/hearing, imaging and pharmacy ancillaries—deliver repeatable, high-margin cash flow that funds growth. PT targets a US $38B outpatient market (2024); DME ~ $170B global (2024); WC medical spend > $40B. Focus on automation, tight SLAs and sourcing to lift EBITDA and free cash.
| Service | 2024 market | Typical EBITDA | Key lever |
|---|---|---|---|
| PT | $38B US | high-teens–mid-20s% | scale, SLAs |
| DME/P&O | $170B global | mid–high | sourcing, logistics |
| Imaging | stable volumes (2019 levels) | thin–steady | throughput |
| Pharmacy | Medicare Part D 49M (2024) | steady | embedded fees |
Preview = Final Product
One Call BCG Matrix
The file you're previewing here is the exact One Call BCG Matrix you'll receive after purchase. No watermarks, no demo text—just the fully formatted, analysis-ready report. It's editable, print-ready, and built for immediate presentation to stakeholders. Purchase unlocks the full file instantly to your inbox. No surprises—just strategic clarity.
Dogs
Legacy Fax/Phone-Only Scheduling
Legacy fax/phone-only scheduling sits in low-growth One Call BCG quadrant: by 2024 over 60% of appointment bookings moved to online portals/APIs, leaving phone/fax easily displaced. It consumes disproportionate staff time with no strategic upside, often breaking even at best while dragging NPS by several points versus digital channels. Sunset or migrate aggressively to reduce labor cost and reclaim service KPIs.
Standalone Medical Record Retrieval
Standalone medical record retrieval is a Dogs business for One Call: highly commoditized with little differentiation and limited pricing power, often generating mid-single-digit to low-double-digit EBITDA margins in 2024. It ties up operations capacity while adding minimal value relative to core services and shows low market share versus specialized vendors focused on retrieval. Divest or bundle only when it directly supports core service economics or reduces operational strain.
Onsite Courier/Document Logistics
Onsite courier/document logistics sits in Dogs: physical document movement is shrinking as payers digitize—US hospital EHR adoption ~96% in 2024 (ONC), and USPS First‑Class Mail volume is down roughly 55% since 2000 (USPS). Operationally messy and margin‑light, it diverts resources from care outcomes. Exit where possible to cut costs and redeploy to digital workflows.
Narrow Regional Ancillary Panels
Dogs: Narrow Regional Ancillary Panels — as of 2024 these operate in small geographies where entrenched local players typically limit market share to under 5%, sales cycles stretch 9–18 months, and wins deliver thin margins; cash often sits idle in routine maintenance and upgrades.
- Small geos: market share <5%
- Sales cycles: 9–18 months
- Thin wins, low margins
- Recommend: consolidate or partner, not own
Generic Wellness Add-ons (non-claim)
Generic wellness add-ons for workers' comp are off-mission for ROI and show low buyer urgency; 2024 insurer pilots reported negligible impact on claim duration or cost and diverted marketing cycles with little return. Reframe tightly to measurable claims outcomes or cut spend to preserve claims ROI.
- Off-mission
- Low urgency
- Hard to prove impact
- Soaks marketing cycles
- Cut or reframe to claims outcomes
Divest phone/fax, records, courier; bookings 60%, EHR 96%
Dogs: legacy phone/fax scheduling, med-record retrieval, onsite courier and narrow regional ancillaries show low growth, thin margins (mid-single to low-double-digit EBITDA in 2024), and shrinking demand—>60% bookings online (2024), hospital EHR adoption 96% (ONC), regional share <5% with 9–18m sales cycles; divest or bundle.
| Asset | 2024 KPI | Action |
|---|---|---|
| Phone/Fax scheduling | 60%+ bookings moved online | Sunset/migrate |
| Record retrieval | EBITDA mid-single–low-double% | Divest/bundle |
| Courier | EHR adoption 96% | Exit |
| Regional ancillaries | Share <5%; 9–18m sales | Consolidate/partner |
Question Marks
Virtual PT / Telerehab
Virtual PT/telerehab is a Question Mark: interest has exploded—telehealth stabilized at roughly 13–17% of outpatient visits (McKinsey 2023–24) and telerehab markets are growing at ~18–20% CAGR—yet market share and proof points still vary by injury type, with some RCTs showing noninferior outcomes for knee/hip OA and certain post-op protocols. Build-out demands high CAPEX and ops investment with low immediate returns; if outcomes consistently rival in-clinic care it can flip to a Star quickly, so invest selectively only alongside rigorous RCT-grade evidence and pilot ROI tracking.
Mobile/At-Home Diagnostics
Speed to scan at home is compelling for immobile injured workers; 2023–24 pilots reported 15–25% fewer facility transfers and ~24-hour faster diagnoses. Network and logistics are complex with front-loaded capital and labor costs (estimated $200–400 subsidy per visit pre-scale). Scale where payer adoption is clear and unit economics work—Medicare Advantage reached ~58% enrollment in 2024.
Digital Injured Worker App (Engagement & Guidance)
Question Mark: Digital Injured Worker App shows attractive retention/adherence uplifts—industry 30‑day retention benchmarks sit near 25% (2023–24), but adoption across sites is uneven. Product polish, EHR/claims integrations and change management required; current P&L shows negative cash flow, burning more cash than revenue. Focus rollout in markets where adjusters champion the tool to accelerate uptake and reduce unit economics losses.
Predictive Triage & Duration Analytics
Predictive Triage & Duration Analytics is a Question Mark with strong growth as payers chase avoidable days, where an avoidable hospital day often costs over $2,000 and payers seek ROI; 2024 pilots reported predictive models with AUCs commonly >0.80 but require trusted explainability and workflow fit. Low share persists until case managers rely on it daily; co-develop with anchor clients to earn routing rights.
- Growth potential: high as avoidable days cost >$2,000/day
- Model bar: AUC >0.80 in 2024 pilots
- Adoption trigger: daily case manager reliance
- Go-to-market: co-develop with anchor clients
Behavioral Health & Pain Management Pathways
Behavioral Health & Pain Management Pathways address clear need in delayed recoveries where referral habits lag; 2024 pilots showed ~35% lower opioid prescriptions and ~20% shorter claim duration versus usual care, though network depth and outcome tracking remain maturing. High upside exists if programs cut opioid risk and claim length; invest with tight clinical protocols and payer-aligned KPIs.
- Referral uptake: low but improving
- Outcomes: tracking systems embryonic
- Impact (2024 pilots): -35% opioids, -20% claim days
- Investment: strict protocols + payer KPIs
Telerehab 13-17% share, 18-20% CAGR - invest selectively
Question Marks: virtual PT/telerehab, digital injured-worker apps, predictive triage and BH pathways show high upside but uneven adoption; telerehab ~13–17% telehealth share (McKinsey 2023–24), telerehab CAGR ~18–20%, MA enrollment ~58% (2024). Pilots: 15–25% fewer transfers, ~24h faster diagnoses, -35% opioids, -20% claim days; invest selectively with RCTs and anchor clients.
| Offering | 2024 Metric | Key Trigger |
|---|---|---|
| Telerehab | 13–17% visits; 18–20% CAGR | RCT parity |
| Injured‑worker app | 30‑day retention ~25% | adjuster champions |
| Predictive triage | AUC >0.80 | daily CM use |